News Conference News TCT 2023 SUMMIT: MV Replacement With Tendyne Shows Promise in Severe MR, MAC Yael L. Maxwell October 30, 2023
News Conference News HFSA 2023 REBALANCE-HF Uncovers HFpEF Group That Responds to Splanchnic Nerve Ablation Todd Neale October 11, 2023
News Conference News ESC 2023 Upgrading to CRT Has Big Impact on HFrEF Patients With High RV Pacing Burden Todd Neale August 26, 2023
News Conference News EuroPCR 2023 Renal Denervation: Exploring Its Potential Beyond Hypertension Todd Neale May 18, 2023
News Daily News Monitoring PA Pressures With CardioMEMS May Help LVAD Patients Todd Neale April 27, 2023
News Conference News THT 2023 Promising Preliminary Results for AccuCinch LV Restoration System in HFrEF Todd Neale March 21, 2023
Presentation THT 2023 Outcomes of cardiogenic shock in patients with chronic systolic vs diastolic heart failure: A nationwide analysis Presenter: Dhairya Nanavaty March 20, 2023
News Conference News ACC 2023 How Dapagliflozin Works in HFpEF: Some Clues From CAMEO-DAPA Todd Neale March 09, 2023
News Opinion Editor's Corner ACC 2023 What’s Going to Be Hot at ACC/WCC 2023? Shelley Wood February 27, 2023
News Daily News Cardiac Biomarkers May Help Refine HF Risk Stratification, Progression L.A. McKeown February 17, 2023
News Daily News Acute Cardiac Events More Common in COVID-19 Patients With Heart Histories Caitlin E. Cox February 10, 2023
News Conference News EACTS 2022 CAST-HF: Could Myocardial Shockwave During CABG Yield Cardiac Regeneration? Shelley Wood October 12, 2022
News Conference News HFSA 2022 REDWOOD-HCM OLE: Aficamten Improves Patient-Measured Health Status L.A. McKeown October 07, 2022
News Daily News Concerning or Reassuring? Long After COVID-19, CMR Still Yields Clues Michael O'Riordan October 03, 2022
News Daily News Exercise Keeps Athletic Heart Supple, Strong, Healthy: JACC Deep Dive Michael O'Riordan September 09, 2022
News Daily News Early LV Recovery After TAVI Points to Better 5-Year Survival Yael L. Maxwell August 01, 2022
News Conference News ESC Heart Failure 2022 Aficamten Safe, Effective for Up to 6 Months in Obstructive HCM: REDWOOD-HCM OLE Todd Neale May 31, 2022
News Conference News EuroPCR 2022 MitraClip ‘Bridge’ Strategy Continues to Help Sickest HF Patients Michael O'Riordan May 20, 2022
News Conference News HRS 2022 Evidence Grows for Conduction-System Pacing as an Alternative to CRT Todd Neale May 05, 2022
News Conference News ACC 2022 Mavacamten Yields Stable Benefits in Obstructive HCM Over Longer Term Shelley Wood April 03, 2022